Internal Medicine, Infectious Disease · Katy, TX
NPI
1184877177
Since 2008
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
2510 W Grand Pkwy N
Katy, TX, 77449
Phone (713) 442-4222
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.0M
980 prescriptions
Company payments, 2025
$1,750
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Jeannette Ouyang-Latimer prescribed most often to Medicare patients was Dovato (Dolutegravir Sodium/Lamivudine), with 202 prescriptions and refills. In total Jeannette Ouyang-Latimer wrote 980 Medicare prescriptions that cost $2.0M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-14.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Dovato Dolutegravir Sodium/Lamivudine | 202 | 202 | 20 | $576K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 161 | 161 | 19 | $619K |
| Doxycycline Hyclate Generic | 56 | 56 | 17 | $2,441 |
| Abacavir-Lamivudine Abacavir Sulfate/Lamivudine | 48 | 56 | Under 11 | $10K |
| Juluca Dolutegravir/Rilpivirine | 47 | 47 | Under 11 | $163K |
| Tivicay Dolutegravir Sodium | 34 | 34 | Under 11 | $72K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 32 | 32 | Under 11 | $112K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 29 | 29 | Under 11 | $104K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 29 | 33 | 12 | $102 |
| Efavirenz Generic | 27 | 41 | Under 11 | $15K |
| Amoxicillin Generic | 24 | 26 | Under 11 | $126 |
| Ertapenem Ertapenem Sodium | 19 | 19 | Under 11 | $13K |
| Azithromycin Generic | 16 | 25 | Under 11 | $442 |
| Cephalexin Generic | 15 | 15 | Under 11 | $265 |
| Ceftriaxone Ceftriaxone Sodium | 14 | 14 | Under 11 | $7,841 |
Brand drugs: 591 claims; generic drugs: 389 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeannette Ouyang-Latimer $1,750 ($1,750 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $1,750.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 1 | $1,750 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.